| Literature DB >> 32731522 |
Zhen Lin1, Yu Zhang1, Fangping Li1, Xiaohui Tan1, Ping Luo1, Huazhong Liu1.
Abstract
Saccharomyces cerevisiae was used as a model to explore the preventive effect of two marine polysaccharides separately derived from Sepia esculenta ink (SIP) and Laminaria japonica (FL) as well as one terrestrial polysaccharides from Eleocharis tuberosa peel (WCPP) on toxic injury induced by acrylamide (AA). The growth of yeast was evaluated by kinetics indexes including doubling time, lag phase and maximum proliferation density. Meanwhile, intracellular redox state was determined by contents of MDA and GSH, and SOD activity. The results showed that AA inhibited yeast growth and destroyed the antioxidant defense system. Supplement with polysaccharides, the oxidative damage of cells was alleviated. According to the growth recovery of yeast, FL and WCPP had similar degree of capacity against AA associated cytotoxicity, while SIP was 1.5~2 folds as strong as FL and WCPP. SIP and FL significantly reduced production of MDA by AA administration. Moreover, SIP, FL and WCPP increased SOD activity and repressed GSH depletion caused by AA.Entities:
Keywords: Saccharomyces cerevisiae; acrylamide; fucoidan from Laminaria japonica; oxidative stress; polysaccharides from Eleocharis tuberosa peel; polysaccharides from Sepia esculenta ink
Mesh:
Substances:
Year: 2020 PMID: 32731522 PMCID: PMC7459515 DOI: 10.3390/md18080395
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1(A) Growth curve of yeast under AA administration at concentrations of 10, 20, 40, 80 and 160 mM and the growth of yeast after cultured 6 h in the presence of AA at 80 mM using spot assay. (B) Growth curve of yeast under SIP or FL or WCPP administration at concentrations of 0.125, 0.25, 0.5, 1 and 2 mg/mL and the growth of yeast after cultured 6 h in the presence of SIP or FL or WCPP at 0.5 mg/mL using spot assay.
The inhibition rate of AA at concentrations of 10, 20, 40, 80 and 160 mM to yeasts.
| Groups | Vehicle | AA | IC50 (mM) | ||||
|---|---|---|---|---|---|---|---|
| Inhibition rate (%) | 0 | Concentration (mM) | 92.64 ± 3.30 | ||||
| 10 | 20 | 40 | 80 | 160 | |||
| 0.41 ± 2.6 | 4.73 ± 3.07 | 12.65 ± 2.58 * | 36.83 ± 1.52 * | 80.91 ± 0.17 * | |||
* Indicated p < 0.05 vs. vehicle group.
The doubling time (Dt) of yeasts under AA at concentrations of 10, 20, 40, 80 and 160 mM, or under polysaccharides at concentrations of 0.125, 0.25, 0.5, 1 and 2 mg/mL.
| Groups | Vehicle | AA | Polysaccharide | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concentration (mM) | Concentration (mg/mL) | ||||||||||||
| 10 | 20 | 40 | 80 | 160 | 0.125 | 0.25 | 0.5 | 1 | 2 | ||||
| SIP | 4.66 ± 0.02 * | 4.65 ± 0.01 * | 4.78 ± 0.05 * | 4.88 ± 0.02 | 4.99 ± 0.04 | ||||||||
| Dt (h) | 4.91 ± 0.02 | 4.95 ± 0.05 | 5.12 ± 0.08 * | 5.43 ± 0.06 * | 7.02 ± 0.08 * | 12.26 ± 0.20 * | FL | 4.96 ± 0.08 | 4.93 ± 0.09 | 4.96 ± 0.05 | 4.98 ± 0.05 | 5.00 ± 0.05 | |
| WCPP | 4.68 ± 0.01 * | 4.66 ± 0.02 * | 4.71 ± 0.05 * | 4.81± 0.02 * | 4.90 ± 0.03 | ||||||||
* Indicated p < 0.05 vs. vehicle group.
The Maximum cell proliferation density (Ym), lag time (1/K) and coefficient of determination for growth curves under AA at concentrations of 10,20,40,80 and 160 mM, or under polysaccharides at concentrations of 0.125, 0.25, 0.5, 1 and 2 mg/mL.
| Groups | Vehicle | AA | Polysaccharide | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ym | 1.80 ± 0.02 | Concentration (mM) | Concentration (mg/mL) | |||||||||
| 10 | 20 | 40 | 80 | 160 | 0.125 | 0.25 | 0.5 | 1 | 2 | |||
| 1.80 ± 0.02 | 1.76 ± 0.03 | 1.66 ± 0.03 * | 1.49 ± 0.02 * | 0.31 ± 0.01 * | SIP | 1.85 ± 0.00 * | 1.86 ± 0.01 * | 1.88 ± 0.01 * | 1.85 ± 0.00 * | 1.79 ± 0.01 | ||
| FL | 1.80 ± 0.01 | 1.81 ± 0.02 | 1.81 ± 0.02 | 1.80 ± 0.01 | 1.77 ± 0.01 | |||||||
| WCPP | 1.87 ± 0.00 * | 1.88 ± 0.01 * | 1.90 ± 0.01 * | 1.86 ± 0.02 * | 1.79 ± 0.01 | |||||||
| 1/K (h) | 3.32 ± 0.02 | 3.36 ± 0.04 | 3.48 ± 0.03 * | 3.65 ± 0.02 * | 4.77 ± 0.02 * | 5.60 ± 0.15 * | SIP | 3.15 ± 0.01 * | 3.14 ± 0.01 * | 3.27 ± 0.03 | 3.36 ± 0.02 | 3.39 ± 0.02 * |
| FL | 3.36 ± 0.05 | 3.34 ± 0.05 | 3.39 ± 0.03 | 3.38 ± 0.03 | 3.36 ± 0.03 | |||||||
| WCPP | 3.20 ± 0.00 * | 3.19 ± 0.01 * | 3.26 ± 0.04 | 3.28 ± 0.04 | 3.31 ± 0.03 | |||||||
| R2 | 0.9919 | 0.9936 | 0.993 | 0.9888 | 0.9884 | 0.9796 | SIP | 0.9921 | 0.9928 | 0.9938 | 0.9945 | 0.9921 |
| FL | 0.9907 | 0.9907 | 0.9912 | 0.9926 | 0.9911 | |||||||
| WCPP | 0.9915 | 0.9916 | 0.9916 | 0.9907 | 0.9916 | |||||||
* indicated p < 0.05 vs. vehicle group.
Figure 2(A–C) Growth curve of yeast under 80 mM AA co-treated with SIP or FL or WCPP administration at concentrations of 0.125, 0.25, 0.5, 1 and 2 mg/mL. (D) The growth of yeast after cultured 6 h in the presence of 80 mM AA combined with SIP or FL or WCPP at 0.5 mg/mL using spot assay. (C,D).
The doubling time (Dt) of yeasts and the inhibition rate under 80 mM AA or 80 mM AA co-treated with SIP or FL or WCPP administration at concentrations of 0.125, 0.25, 0.5, 1 and 2 mg/mL.
| Groups | Vehicle | 80 mM AA | Combination | |||||
|---|---|---|---|---|---|---|---|---|
| Concentration of Polysaccharide (mg/mL) | ||||||||
| 0.125 | 0.25 | 0.5 | 1 | 2 | ||||
| SIP + 80 mM AA | 6.60 ± 0.05 * | 6.75 ± 0.01 * | 6.84 ± 0.13 * | 7.30 ± 0.05 * | 7.82 ± 0.02 | |||
| Dt (h) | 5.23 ± 0.02 * | 7.73 ± 0.04 | FL + 80 mM AA | 7.63 ± 0.20 | 7.23 ± 0.18 * | 7.16 ± 0.15 * | 7.41 ± 0.08 * | 7.54 ± 0.07 * |
| WCPP + 80 mM AA | 7.07 ± 0.19 * | 7.09 ± 0.09 * | 7.23 ± 0.07 * | 7.63 ± 0.03 * | 7.87 ± 0.06 * | |||
| SIP + 80 mM AA | 29.69 ± 0.32 * | 31.31 ± 0.46 * | 31.91 ± 0.01 * | 35.84 ± 0.98 * | 40.35 ± 0.17 | |||
| Inhibition rate (%) | 0 * | 39.76 ± 0.50 | FL + 80 mM AA | 38.04 ± 1.15 | 34.69 ± 1.41 * | 34.10 ± 1.12 * | 36.13 ± 0.67 * | 37.04 ± 0.35 * |
| WCPP + 80 mM AA | 34.96 ± 1.07 * | 34.16 ± 0.86 * | 34.41 ± 0.01 * | 37.31 ± 0.34 * | 39.96 ± 0.25 | |||
* Indicated p < 0.05 vs. 80 mM AA group.
The Maximum cell proliferation density (Ym), lag time (1/K) and coefficient of determination for growth curves under 80 mM AA or 80 mM AA co-treated with SIP or FL or WCPP administration at concentrations of 0.125, 0.25, 0.5, 1 and 2 mg/mL.
| Groups | Vehicle | 80 mM AA | Combination | |||||
|---|---|---|---|---|---|---|---|---|
| Concentration of Polysaccharide (mg/mL) | ||||||||
|
|
|
|
|
| ||||
| SIP + 80 mM AA | 1.57 ± 0.17 * | 1.58 ± 0.00 * | 1.60 ± 0.01 * | 1.59 ± 0.01 * | 1.58 ± 0.01 * | |||
| Ym | 1.83 ± 0.02 * | 1.53 ± 0.00 | FL + 80 mM AA | 1.60 ± 0.02 * | 1.57 ± 0.02 | 1.56 ± 0.02 | 1.57 ± 0.02 | 1.53 ± 0.02 |
| WCPP + 80 mM AA | 1.55 ± 0.03 | 1.60 ± 0.00 * | 1.62 ± 0.02 * | 1.61 ± 0.02 * | 1.60 ± 0.01 * | |||
| SIP + 80 mM AA | 5.17 ± 0.03 * | 5.32 ± 0.01 * | 5.42 ± 0.09 * | 5.70 ± 0.01 * | 6.03 ± 0.05 * | |||
| 1/K (h) | 3.91 ± 0.01 * | 5.82 ± 0.01 | FL + 80 mM AA | 5.89 ± 0.08 | 5.53 ± 0.10 * | 5.44 ± 0.05 * | 5.61 ± 0.03 * | 5.58 ± 0.03 * |
| WCPP + 80 mM AA | 5.52 ± 0.13 * | 5.60 ± 0.03 * | 5.66 ± 0.02 * | 5.85 ± 0.05 | 6.04 ± 0.07 * | |||
| SIP + 80 mM AA | 0.988 | 0.9897 | 0.9907 | 0.991 | 0.991 | |||
| R2 | 0.9896 | 0.9898 | FL + 80 mM AA | 0.9892 | 0.9886 | 0.9893 | 0.9892 | 0.9885 |
| WCPP + 80 mM AA | 0.9891 | 0.9876 | 0.9864 | 0.9848 | 0.9861 | |||
* Indicated p < 0.05 vs. 80 mM AA group.
Figure 3(A–C) The trend of MDA level, GSH level and SOD activity at 2, 6, 10, 14 and 18 h in each group. ABCD indicates p < 0.05 between groups, abcd indicates p < 0.05 within group.